Intellipharmaceutics Logo

Email this page: News Release

FDA Grants Fast Track Designation for Intellipharmaceutics Rexista(TM) Oxycodone XR Incorporating PODRAS(TM) Technology

 

Separate multiple addresses with commas. Maximum 200 characters.
 
 


These email addresses will be used to email the page on your behalf and will not be used by Intellipharmaceutics for any marketing purposes.

Send:       


 
This helps Intellipharmaceutics prevent automated submissions.